Key result
In 2016, Acute Flaccid Paralysis surveillance in Iran recorded 776 cases, yielding a non-polio AFP rate of 4.2 per 100,000.
Observational (n=776)
Yes
The report details the AFP surveillance performance indicators for Iran in 2016, showing a non-polio AFP rate of 4.2 per 100,000.
Answers are grounded in this paper and cite their sources.
AFP surveillance supports polio eradication; leaves open optimal certification criteria in low-transmission settings.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Khazaei et al. (2017) conducted an observational in Acute Flaccid Paralysis (n=776). Acute Flaccid Paralysis (AFP) surveillance was evaluated on Non-polio AFP rate. In 2016, Acute Flaccid Paralysis surveillance in Iran recorded 776 cases, yielding a non-polio AFP rate of 4.2 per 100,000.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: